Clinical trials
Phase 3 Cerebrovascular Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Withdrawn | 2 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Brian Silver | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| AB Science | 1 |
| Augusta University | 1 |
| Bayer | 1 |
| Beijing Tiantan Hospital | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Boston Children's Hospital | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cerebrovascular Disorders | 34 |
| Stroke | 15 |
| Cardiovascular Diseases | 11 |
| Ischemic Stroke | 8 |
| Heart Diseases | 6 |
| Coronary Disease | 5 |
| Vascular Diseases | 5 |
| Atherosclerosis | 4 |
| Brain Diseases | 4 |
| Cerebral Infarction | 4 |
Trials
Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.